For example, treatment of breast cancer cells that lack expression for the receptors of estrogen, progesterone and human epidermal growth factor receptor 2 (HER2), commonly known as “triple-negative”, with esomeprazole significantly and dose-dependently inhibited their growth [10]. Here, ERBB2 is linked to breast carcinoma.